Kazuyoshi Sato
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: August 02, 2023
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.
Journal: Cardiovascular endocrinology & metabolism
Published: May 29, 2023
Cross-sectional survey of hypertension management in clinical practice in Japan: the Kanagawa Hypertension Study 2021 conducted in collaboration with Japan Medical Association Database of Clinical Medicine.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: March 02, 2023
Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Journal: Scientific reports
Published: June 05, 2022
Concomitant treatment with insulin and sodium-glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score-matched analysis.
Journal: Journal of diabetes investigation
Published: March 29, 2022
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists.
Journal: Diabetes research and clinical practice
Published: November 04, 2021
Polypharmacy influences the renal composite outcome in patients treated with sodium-glucose cotransporter 2 inhibitors.
Journal: Clinical and translational science
Published: June 24, 2021
The Comparison of the Kidney Effects of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide 1 Agonist-Administered Concomitant with Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease.
Journal: Journal of diabetes research
Published: May 09, 2021
Comparison of questionnaire responses regarding awareness of Japanese Society of Hypertension guidelines for the management of hypertension between 2014 and 2019 in primary care.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: January 10, 2021
Sodium-glucose cotransporter 2 inhibitor-induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score-matched model analysis in Japan.
Journal: Journal of diabetes investigation
Published: October 06, 2020
Last Updated: 09/26/2026